Nuveen
TLX icon

Nuveen’s Telix Pharmaceuticals TLX Stock Holding History

Nuveen’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.1K Buy
+1,071
New +$12.2K ﹤0.01% 4507

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Aubrey Capital Management
Aubrey Capital Management Edinburgh, United Kingdom $115M AUM 51.42% 1-Year Est. Return
WoodTrust Financial
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Nuveen's TLX Position: Q3 2026 in Review

Nuveen opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 1,071 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #4507 among its holdings.

31 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • Nuveen held 1,071 shares of Telix Pharmaceuticals worth $12.1K as of Q3 2026.
  • Telix Pharmaceuticals was a new Nuveen position in Q3 2026.
  • Telix Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4507 holding.
  • 31 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.